Glycopeptide-induced vasculitis - Cross-reactivity between vancomycin and teicoplanin

C. Marshall; A. Street; K. Galbraith

doi:10.1016/S0163-4453(98)91077-5

Glycopeptide-induced vasculitis - Cross-reactivity between vancomycin and teicoplanin

C. Marshall, A. Street, K. Galbraith

Research output: Contribution to journal › Article › Research › peer-review

21 Citations (Scopus)

Abstract

Teicoplanin has been suggested for use in patients suffering complications from vancomycin. We describe two patients who developed a vasculitic rash whilst on vancomycin with recrudescence of the rash with subsequent teicoplanin therapy.

Original language	English
Pages (from-to)	82-83
Number of pages	2
Journal	Journal of Infection
Volume	37
Issue number	1
DOIs	https://doi.org/10.1016/S0163-4453(98)91077-5
Publication status	Published - 1 Jan 1998
Externally published	Yes

Access to Document

10.1016/S0163-4453(98)91077-5

Link to publication in Scopus

Cite this

@article{4c8b40a1bdc845d19d444a774c9a84e2,

title = "Glycopeptide-induced vasculitis - Cross-reactivity between vancomycin and teicoplanin",

abstract = "Teicoplanin has been suggested for use in patients suffering complications from vancomycin. We describe two patients who developed a vasculitic rash whilst on vancomycin with recrudescence of the rash with subsequent teicoplanin therapy.",

author = "C. Marshall and A. Street and K. Galbraith",

year = "1998",

month = jan,

day = "1",

doi = "10.1016/S0163-4453(98)91077-5",

language = "English",

volume = "37",

pages = "82--83",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Glycopeptide-induced vasculitis - Cross-reactivity between vancomycin and teicoplanin

AU - Marshall, C.

AU - Street, A.

AU - Galbraith, K.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Teicoplanin has been suggested for use in patients suffering complications from vancomycin. We describe two patients who developed a vasculitic rash whilst on vancomycin with recrudescence of the rash with subsequent teicoplanin therapy.

AB - Teicoplanin has been suggested for use in patients suffering complications from vancomycin. We describe two patients who developed a vasculitic rash whilst on vancomycin with recrudescence of the rash with subsequent teicoplanin therapy.

UR - http://www.scopus.com/inward/record.url?scp=0031712519&partnerID=8YFLogxK

U2 - 10.1016/S0163-4453(98)91077-5

DO - 10.1016/S0163-4453(98)91077-5

M3 - Article

C2 - 9733391

AN - SCOPUS:0031712519

VL - 37

SP - 82

EP - 83

JO - Journal of Infection

JF - Journal of Infection

SN - 0163-4453

IS - 1

ER -